Panacea Biotec Ltd.

PANACEABIO

Market Cap
₹831 Cr.
P/E
0.00

Panacea Biotec Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

3 Yes

Positive for this company

1 Neutral

Neutral for this company

12 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
-3.94%
3yr Average
61.22%
5yr Average
19.34%
Net Profit Margin
Latest
-7.23%
3yr Average
44.07%
5yr Average
20.95%
ROCE
Latest
-9.07%
3yr Average
-2.75%
5yr Average
-10.17%
Debt to Equity
Latest
0.02
3yr Average
-1.17
5yr Average
0.41
Market Share
0.01% (as of Jul 22)
Anti - Diabetes - Market Share
0.01% (as of Jul 22)
Anti-Infectives - Market Share
3.44% (as of Nov 21)
Antineo Plastic - Market Share
0.04% (as of Nov 21)
Blood Related - Market Share
0.01% (as of Jul 18)
Cardiovascular - Market Share
0.02% (as of Nov 21)
Endocrinology - Market Share
0% (as of Jul 22)
Gastro-Intestinal - Market Share
0.03% (as of Nov 21)
Gynecology - Market Share
0.01% (as of Nov 21)
Neurological - Market Share
0.25% (as of Nov 21)
Pain - Market Share
0.04% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.02% (as of Nov 21)
Respiratory - Market Share
4.02% (as of Jul 22)
Vaccines - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

Latest
|
locked
Historic

Location Wise Break-Up -Vaccines

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up -India

Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline